BBSRC Portfolio Analyser
Award details
Evaluation of mucosal vaccination with live, attenuated mutant bovine respiratory syncytial viruses
Reference
BBS/E/I/00001325
Principal Investigator / Supervisor
Dr Geraldine Taylor
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
84,856
Status
Completed
Type
Institute Project
Start date
01/04/2007
End date
31/03/2010
Duration
36 months
Abstract
The principal scientific objectives are to: 1. Determine the effects of mucosal vaccination with live, attenuated mutant BRSV on the magnitude and duration of BRSV-specific CD4+ and CD8+ T-cell memory; 2 Determine the effects of mucosal vaccination with live, attenuated mutant BRSV on the magnitude and duration of BRSV-specific antibodies in serum and nasal secretions; 3. Determine the duration of protective immunity induced by mucosal vaccination with live, attenuated mutant BRSV; 4. Investigate the interaction of Mycoplasma bovis with bovine airway epithelial cells and macrophages.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
Animal Health, Immunology, Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search